Stage IV Hepatocellular Carcinoma AJCC v7
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11714 | Durvalumab | 1 | Active Not Recruiting | 1 |
| DB11918 | Guadecitabine | 1 | Active Not Recruiting | 1 |
| DB12340 | Navitoclax | 1 | Active Not Recruiting | 1 |
| DB00398 | Sorafenib | 1 | Active Not Recruiting | 1 |
| DB12887 | Tazemetostat | 1 | Withdrawn | 1 |
| DB11574 | Elbasvir | 2 | Completed | 1 |
| DB11575 | Grazoprevir | 2 | Completed | 1 |
| DB09037 | Pembrolizumab | 2 | Completed | 1 |
| DB00811 | Ribavirin | 2 | Completed | 1 |
| DB00398 | Sorafenib | 2 | Completed | 1 |
| DB00997 | Doxorubicin | 3 | Completed | 1 |
| DB00398 | Sorafenib | 3 | Completed | 1 |